diethylnitrosamine has been researched along with fluorodeoxyglucose f18 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jeon, TJ; Kang, JH; Kim, KI; Kim, KM; Ko, YO; Lee, TS; Lee, YJ; Lim, SM; Nahm, SS; Park, JA; Park, JH; Park, YS; Yu, DY | 1 |
| Chung, YA; Ham, HJ; Jang, KS; Jung, YJ; Lee, J; Lee, JH; Maeng, LS; Park, MS; Park, SI | 1 |
2 other study(ies) available for diethylnitrosamine and fluorodeoxyglucose f18
| Article | Year |
|---|---|
Evaluation of diethylnitrosamine- or hepatitis B virus X gene-induced hepatocellular carcinoma with 18F-FDG PET/CT: a preclinical study.
Topics: Animals; Carcinoma, Hepatocellular; Diethylnitrosamine; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Hexokinase; Liver Neoplasms, Experimental; Longitudinal Studies; Magnetic Resonance Imaging; Male; Mice, Inbred C57BL; Mice, Transgenic; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Trans-Activators; Viral Regulatory and Accessory Proteins | 2015 |
Evaluation of 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in rat models with hepatocellular carcinoma with liver cirrhosis.
Topics: Animals; Carcinoma, Hepatocellular; Diethylnitrosamine; Feasibility Studies; Fluorodeoxyglucose F18; Liver Cirrhosis; Liver Neoplasms; Male; Metabolic Clearance Rate; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Tomography, X-Ray Computed | 2015 |